Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Pancreatic Adenocarcinoma × Leucovorin × Clear all

Phase

Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 179 Rectal Neoplasms 98 Colonic Neoplasms 73 Stomach Neoplasms 63 Pancreatic Neoplasms 51 Neoplasm Metastasis 46 Esophageal Neoplasms 32 Neoplasms 23 Lymphoma 21 Leukemia 21 Adenocarcinoma Of Esophagus 21 Precursor Cell Lymphoblastic Leukemia-Lymphoma 17 Burkitt Lymphoma 16 Adenocarcinoma 15 Carcinoma, Hepatocellular 14 Cholangiocarcinoma 13 Biliary Tract Neoplasms 13 Gallbladder Neoplasms 8 Bile Duct Neoplasms 8 Lymphoma, Mantle-Cell 7 Colorectal Cancer Metastatic 6 Osteosarcoma 5 Lymphoma, Large B-Cell, Diffuse 5 Liver Neoplasms 5 Esophageal Squamous Cell Carcinoma 5 Dendritic Cell Sarcoma, Interdigitating 5 Breast Neoplasms 5 Sarcoma 4 Lymphoma, Non-Hodgkin 4 Gastrointestinal Neoplasms 4

Interventions

Gemcitabine 5 Albumin-Bound Paclitaxel 4 Taxes 3 Fluorouracil 3 dehydroftorafur 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Oxaliplatin 2 130-nm albumin-bound paclitaxel 2 irinotecan sucrosofate 1 indusatumab 1 Surgical Procedures, Operative 1 S 1 (combination) 1 Radiotherapy, Image-Guided 1 Pancreatectomy 1 Losartan 1 Leucovorin 1 Irinotecan 1 Folfox protocol 1 Cetuximab 1 Anesthesia, General 1 Anesthesia 1 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03528785 2021-08-02

nITRo

Centro Ricerche Cliniche di Verona

Phase 2 Unknown

Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡